Cargando…

Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches

The pathological condition of insulin resistance prevents the neuroprotective effects of insulin. Numerous studies have demonstrated that insulin resistance, as an independent risk factor for ischemic stroke, accelerates the formation of thrombosis and promotes the development of atherosclerosis, bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Peng-Fei, Zhang, Hua-Sheng, Wang, Jie, Gao, Yong-Yue, Mao, Jian-Nan, Hang, Chun-Hua, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798125/
https://www.ncbi.nlm.nih.gov/pubmed/36589857
http://dx.doi.org/10.3389/fendo.2022.1092431
_version_ 1784860839563493376
author Ding, Peng-Fei
Zhang, Hua-Sheng
Wang, Jie
Gao, Yong-Yue
Mao, Jian-Nan
Hang, Chun-Hua
Li, Wei
author_facet Ding, Peng-Fei
Zhang, Hua-Sheng
Wang, Jie
Gao, Yong-Yue
Mao, Jian-Nan
Hang, Chun-Hua
Li, Wei
author_sort Ding, Peng-Fei
collection PubMed
description The pathological condition of insulin resistance prevents the neuroprotective effects of insulin. Numerous studies have demonstrated that insulin resistance, as an independent risk factor for ischemic stroke, accelerates the formation of thrombosis and promotes the development of atherosclerosis, both of which are major mechanisms of ischemic stroke. Additionally, insulin resistance negatively affects the prognosis of patients with ischemic stroke regardless of whether the patient has diabetes, but the mechanisms are not well studied. We explored the association between insulin resistance and the primary mechanisms of brain injury in ischemic stroke (inflammation, oxidative stress, and neuronal damage), looking for potential causes of poor prognosis in patients with ischemic stroke due to insulin resistance. Furthermore, we summarize insulin resistance therapeutic approaches to propose new therapeutic directions for clinically improving prognosis in patients with ischemic stroke.
format Online
Article
Text
id pubmed-9798125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97981252022-12-30 Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches Ding, Peng-Fei Zhang, Hua-Sheng Wang, Jie Gao, Yong-Yue Mao, Jian-Nan Hang, Chun-Hua Li, Wei Front Endocrinol (Lausanne) Endocrinology The pathological condition of insulin resistance prevents the neuroprotective effects of insulin. Numerous studies have demonstrated that insulin resistance, as an independent risk factor for ischemic stroke, accelerates the formation of thrombosis and promotes the development of atherosclerosis, both of which are major mechanisms of ischemic stroke. Additionally, insulin resistance negatively affects the prognosis of patients with ischemic stroke regardless of whether the patient has diabetes, but the mechanisms are not well studied. We explored the association between insulin resistance and the primary mechanisms of brain injury in ischemic stroke (inflammation, oxidative stress, and neuronal damage), looking for potential causes of poor prognosis in patients with ischemic stroke due to insulin resistance. Furthermore, we summarize insulin resistance therapeutic approaches to propose new therapeutic directions for clinically improving prognosis in patients with ischemic stroke. Frontiers Media S.A. 2022-12-15 /pmc/articles/PMC9798125/ /pubmed/36589857 http://dx.doi.org/10.3389/fendo.2022.1092431 Text en Copyright © 2022 Ding, Zhang, Wang, Gao, Mao, Hang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ding, Peng-Fei
Zhang, Hua-Sheng
Wang, Jie
Gao, Yong-Yue
Mao, Jian-Nan
Hang, Chun-Hua
Li, Wei
Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title_full Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title_fullStr Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title_full_unstemmed Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title_short Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
title_sort insulin resistance in ischemic stroke: mechanisms and therapeutic approaches
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798125/
https://www.ncbi.nlm.nih.gov/pubmed/36589857
http://dx.doi.org/10.3389/fendo.2022.1092431
work_keys_str_mv AT dingpengfei insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT zhanghuasheng insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT wangjie insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT gaoyongyue insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT maojiannan insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT hangchunhua insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches
AT liwei insulinresistanceinischemicstrokemechanismsandtherapeuticapproaches